<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02596191</url>
  </required_header>
  <id_info>
    <org_study_id>2014-10</org_study_id>
    <nct_id>NCT02596191</nct_id>
  </id_info>
  <brief_title>Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers</brief_title>
  <acronym>CMT-TOOLS</acronym>
  <official_title>Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a 2-year follow-up study of a cohort of 60 CMT1A patients. The objective is to
      identify markers allowing to better understand the phenotypic variability observed on
      patients with CMT1A, to identify predictive markers of the disease's progression and to
      provide validated measurement tools that can be used as outcome measures in future clinical
      trials.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of functional scores at 3 different times</measure>
    <time_frame>3 months, 12 months and 24 months</time_frame>
    <description>several functional scores to evaluate the severity and the progression of the disease will be performed and compared (CMTNS, CMTNDS, CMTNS2, ONLS)</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Charcot-Marie-Tooth Disease Type 1A</condition>
  <arm_group>
    <arm_group_label>patients with mild CMT 1A disease</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Charcot-Marie-Tooth Neuropathy Score between 1 and 10</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with moderate CMT 1A disease</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Charcot-Marie-Tooth Neuropathy Score between 11 and 20</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with severe CMT 1A disease</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Charcot-Marie-Tooth Neuropathy Score ≥21</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Healthy volunteers</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clinical evaluation</intervention_name>
    <arm_group_label>patients with mild CMT 1A disease</arm_group_label>
    <arm_group_label>patients with moderate CMT 1A disease</arm_group_label>
    <arm_group_label>patients with severe CMT 1A disease</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>electrophysiological record</intervention_name>
    <arm_group_label>patients with mild CMT 1A disease</arm_group_label>
    <arm_group_label>patients with moderate CMT 1A disease</arm_group_label>
    <arm_group_label>patients with severe CMT 1A disease</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Muscle MRI</intervention_name>
    <arm_group_label>patients with mild CMT 1A disease</arm_group_label>
    <arm_group_label>patients with moderate CMT 1A disease</arm_group_label>
    <arm_group_label>patients with severe CMT 1A disease</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood samples analysis</intervention_name>
    <arm_group_label>patients with mild CMT 1A disease</arm_group_label>
    <arm_group_label>patients with moderate CMT 1A disease</arm_group_label>
    <arm_group_label>patients with severe CMT 1A disease</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with CMT 1A disease

          -  Diagnosis of CMT 1A confirmed by genotyping (duplication of the 17p11.2 region)

        Exclusion Criteria:

          -  Patients suffering from co-morbidity at the origin of peripheral neuropathy (diabetes,
             hypothyroidism, renal insufficiency, drugs...) or muscle, articular, rheumatological
             disease

          -  With HIV or cancer

          -  With a significant progressive disease in the previous month

          -  With a contra-indication for MRI

          -  With a dislocation, fracture, or recent surgery (less than 6 months before inclusion)

          -  with alcohol or psychoactive substances abuse

          -  Treated by an anti-inflammatory drug over the past four weeks

          -  Pregnant or breastfeeding women

          -  Homeless patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Urielle Desalbres</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hôpitaux de Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shahram ATTARIAN, MD</last_name>
    <email>shahram.attarian@ap-hm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assistance Publique Hôpitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shahram Attarian, MD</last_name>
      <email>shahram.attarian@ap-hm.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 30, 2015</study_first_submitted>
  <study_first_submitted_qc>November 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2015</study_first_posted>
  <last_update_submitted>November 3, 2015</last_update_submitted>
  <last_update_submitted_qc>November 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tooth Diseases</mesh_term>
    <mesh_term>Charcot-Marie-Tooth Disease</mesh_term>
    <mesh_term>Nerve Compression Syndromes</mesh_term>
    <mesh_term>Hereditary Sensory and Motor Neuropathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

